Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT04774393 · RECRUITING
Trial details
- NCT number
- NCT04774393
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2027-11-29
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.